Back to 
BlackRock, Inc.
BlackRock, Inc.
ARQT6 quarters
Position history for BlackRock, Inc.'s holdings in ARCUTIS BIOTHERAPEUTICS INC
BlackRock, Inc. holds 9.2M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $216.8M as of 2026-Q1. The position was increased (+1.1% shares). ARQT represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$216.8M
Current Shares
9.2M
Total Value Change
+$89.3M
Total Shares Change
+51,853
Quarter-by-Quarter History
Other major holders of ARQT: JENNISON ASSOCIATES LLC, VANGUARD GROUP INC